U.S. Insurance Stock News

Niagen Bioscience (NAGE) has been drawing attention after its recent rebranding from ChromaDex Corporation, shifting investor focus toward its healthy aging product portfolio and proprietary NIAGEN ingredient as the stock reacts to this corporate transition. See our latest analysis for Niagen Bioscience. Recent trading has been weaker for Niagen Bioscience, with the share price at about US$3.30 after declining around 15% over the past month and about 47% year to date. The 3 year total...

The Supreme Court’s decision to uphold birthright citizenship removes a major source of uncertainty for millions of families and the employers that rely on them. For investors, clearer immigration rules can mean steadier labor supply and more predictable consumer demand, which can matter as much as any earnings report. This article looks at three stocks exposed to this ruling through their dependence on immigrant workers or diverse customer bases. Each one could see business conditions shaped...

Old Republic International (ORI) has drawn investor attention after its recent share performance, with the stock closing at $41.49 and logging gains over the past week, month, and past 3 months. See our latest analysis for Old Republic International. Taking a step back, Old Republic International’s recent 1 month share price return of 11.44% sits alongside a year to date share price decline of 4.11%. Its 5 year total shareholder return of 143.06% highlights how long term holders have been...

With inflation readings mixed across regions, bond yields shifting and oil markets adjusting to Hormuz reopening, many investors are looking for companies where analysts still see clear earnings growth potential and balance sheets that can handle bumps in the macro data. The Healthy high growth potential screener focuses exactly on that combination, filtering for stocks where analysts expect solid earnings expansion over the next 3 years and financial positions that pass key quality checks...

Plains All American Pipeline (PAA) stock is in focus after the company entered a new unsecured revolving credit agreement, expanding committed borrowing capacity to $2.7b and replacing its prior bank facilities. See our latest analysis for Plains All American Pipeline. The new revolving credit agreement lands at a time when Plains All American Pipeline’s share price has risen 21.47% year to date, while its 1 year total shareholder return of 31.17% and 5 year total shareholder return of...

Easterly Government Properties recently closed a new five-year US$200,000,000 senior unsecured term loan facility, which includes an accordion feature allowing total commitments to rise to as much as US$250,000,000 and matures in June 2031. The company plans to use the proceeds to repay borrowings under its US$400,000,000 revolving credit facility and for general corporate purposes, effectively reshaping its mix of revolving and term debt while locking in pricing tied to its current leverage...

The obesity and metabolic drug space is suddenly in the spotlight, and not just because of headlines around GLP-1 treatments. A Supreme Court ruling on executive power, Medicare’s move to start covering obesity drugs, and a record close for the Dow are all feeding into a new conversation about where risk and opportunity may sit in this corner of healthcare. This article looks at 3 stocks from our Healthcare Sector, Obesity and Metabolic Drug Manufacturers screener that appear particularly...

Clear Channel Outdoor Holdings (CCO) has been added to several Russell indices, including the Russell 2000, 2500, 3000, and related value and completeness benchmarks. This change is drawing fresh attention from index tracking and institutional investors. See our latest analysis for Clear Channel Outdoor Holdings. At a share price of $2.40, Clear Channel Outdoor Holdings has seen short term share price returns move only modestly. A 13.21% year to date share price return sits alongside a...

Procore Technologies (PCOR) has rolled out new portfolio management tools, capital planning features, and a connected Common Data Environment for UK and Ireland projects, with plans to extend the CDE across EMEA. See our latest analysis for Procore Technologies. Despite these product launches, Procore Technologies’ recent share price performance has been weak. The stock closed at $41.0 and recorded a 30 day share price return down 17.16% and a year to date share price return down 41.46%,...

Recently, Hancock Whitney was highlighted as a top dividend stock for income-focused investors, recognized for its consistent dividend increases, competitive yield, and conservative payout ratio that supports dividend sustainability. This recognition emphasizes how the bank’s disciplined capital management and dividend track record are increasingly central to how investors assess its appeal. We’ll now examine how this renewed focus on Hancock Whitney’s dividend consistency may influence its...

Index additions put Custom Truck One Source in focus Custom Truck One Source (CTOS) has attracted fresh attention after being added to several Russell growth indices, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, and Small Cap Comp Growth benchmarks. See our latest analysis for Custom Truck One Source. Custom Truck One Source has already seen strong share price momentum, with a 30 day share price return of 24.7%, a 90 day return of 81.9% and a year to date gain of...

Principal Financial Group, Inc. was removed from the Russell 1000 Dynamic Index on 27 June 2026, prompting index-tracking funds to adjust their holdings and rebalance portfolios accordingly. This index removal could affect how Principal Financial Group’s stock is owned and traded, as benchmark-aware investors reassess its role in diversified portfolios. Now we’ll examine how the Russell 1000 Dynamic Index removal may influence Principal Financial Group’s investment narrative and longer-term...

AEVEX (AVEX) stock is back in focus after the company reported a new US$50 million contract from the United States Air Force to expand unmanned mission support and long range precision strike capabilities. See our latest analysis for AEVEX. Those contracts and AEVEX’s recent additions to several Russell indices have put the stock back in the spotlight. Yet the 30 day share price return is down 53.37% and the year to date share price return is down 33.38%, even after a 4.30% one day and 2.63%...

The sudden decision for Medicare to temporarily cover obesity drugs like Wegovy and Zepbound has put a spotlight on pharmaceutical companies working in obesity and metabolic disorders. With millions of eligible seniors now facing a defined $50 monthly copay and a clear end date for coverage in 2027, the stakes are high for both investors and patients. This article looks at how that catalyst connects to three stocks exposed to the news, all drawn from a focused screener of larger healthcare...

AI heavyweights in the Magnificent 7 have just seen about US$2.3t in value wiped away as investors question massive, often debt-fueled, infrastructure spending and wait for second quarter earnings to show clearer payoffs. At the same time, semiconductor stocks linked to that same AI buildout are seeing stronger interest, helped by chip supply bottlenecks, higher memory prices and solid reports from companies such as Micron. This article looks at 3 stocks from a Semiconductor Stocks screener...

In late June 2026, BioMarin Pharmaceutical was added to several Russell indexes, including the Russell 1000 Defensive and Russell 2500 Value benchmarks, and reported new VOXZOGO and BMN 333 data at ENDO 2026 showing sustained growth benefits and favorable safety in skeletal dysplasia indications. The combination of broader index inclusion and emerging evidence that VOXZOGO and BMN 333 may expand treatment options in achondroplasia and hypochondroplasia could influence how investors view...

In June 2026, AbCellera Biologics announced a preclinical research collaboration, option, and license agreement with Jazz Pharmaceuticals to discover and develop next-generation T-cell engaging multispecific antibodies for gastrointestinal cancers and other solid tumors, with Jazz gaining exclusive global development and commercialization rights on exercising program-specific options. The deal structure, featuring US$56,000,000 in upfront payments for two programs, a further US$28,000,000 on...

On 27 June 2026, GPGI, Inc. (NYSE:GPGI) was removed from a broad suite of Russell indexes, including the Russell 3000E, Russell 2000 Value, and multiple Microcap benchmarks, following the FTSE Russell reconstitution process. This sweeping loss of index inclusion can reshape GPGI’s shareholder base and liquidity profile, as index-linked funds may adjust or reduce their positions. We’ll now examine how GPGI’s broad Russell index removals may affect its investment narrative built around premium...

Clover Health Investments said that Brady Priest stepped down on July 3, 2026, as CEO of Clover Care Services, its home-care unit, with his duties redistributed across the existing executive team to more closely align that business with the rest of the company. This shift away from a standalone home-care chief toward a more centralized leadership structure could meaningfully alter how Clover integrates technology, care delivery, and resource allocation across its operations. We’ll now...

On 27 June 2026, Simon Property Group, Inc. was removed from several Russell value benchmarks and added to the Russell 1000 Growth-Defensive and Russell 1000 Defensive indices, reflecting a reclassification of the stock’s profile in index construction. This shift away from value-oriented indices toward growth and defensive benchmarks could alter how index funds and active managers position Simon within diversified portfolios. Next, we’ll examine how Simon’s move from value to...

Regulators are turning up the heat on technology, data, and digital infrastructure, and that shift is increasingly reflected in how investors think about risk and opportunity. When rules tighten around cybersecurity, compliance, and critical systems, some stocks can find themselves better placed to win contracts, build trust, or secure longer term revenue visibility, while others may face heavier costs or business friction. This article looks at 3 stocks from our Regulatory Beneficiaries in...

NWPX Infrastructure (NWPX) was recently added to several Russell growth indices, a shift that can influence how index funds and institutional investors approach the stock and its role in diversified portfolios. See our latest analysis for NWPX Infrastructure. Against this backdrop, NWPX Infrastructure has shown strong momentum, with a 30-day share price return of 26.63%, a 90-day share price return of 91.84%, and a 1-year total shareholder return of 264.23%. This suggests investors are...

Index reshuffle puts Liberty Energy in the growth spotlight Liberty Energy (LBRT) has shifted across the Russell index family, joining several growth benchmarks while exiting value and defensive indexes. This change can influence how institutional investors position around the stock. See our latest analysis for Liberty Energy. Despite Liberty Energy's recent inclusion in several Russell growth indexes, short term share price momentum has cooled, with the stock down 10.22% over the past month...

In late June 2026, HNI Corporation (NYSE:HNI) was removed from several Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indexes, while simultaneously being added to the Russell 2000 Dynamic Index. These index changes can alter how index funds and quantitative investors hold HNI, potentially reshaping its shareholder base and trading behavior without changing the company’s underlying fundamentals. We’ll now examine how HNI’s shift out of multiple Russell...